CMPP Exam Questions with Correct Answers Latest Update 2025-2026
COPE - Answers Committee on Publication Ethics
CSE - Answers Council of Science Editors
FDAAA 2007 - Answers Food and Drug Administration Amendment Act
CONSORT - Answers Consolidated Standard of Reporting Trials - randomized trials with
checklist and flowchart
WAME - Answers World Association of Medical Editors
EQUATOR - Answers Enhancing the Quality and Transparency of Health Rese
PhRMA - Answers Pharmaceutical Research and Manufacturers of America
AMWA - Answers American Medical Writers Association
EMWA - Answers European Medical Writers Association
ICMJE - Answers International Committee of Medical Journal Editors
PRISMA - Answers Preferred Reporting Items for Systematic Reviews and Meta-Analyses
(checklist)
FDA guidance on reprints - Answers Section 401 Food & Drug Administration Modernization Act
FDA guidance on communication of unapproved indications - Answers Unapproved use of
approved drugs "off label"
GPP3 - Answers Good publication practice - understand the document completely and highlight
totally understand document
Joint position on publication of clinical trial results - Answers Which trials, when submitted,
where submitted and what information
All industry clinical trials - positive of negative
Minimum all phase 3 clinical trials to be published
12 months to no later than 18 months
Primary pub - results from all center
Secondary - sub group analysis or results from individual centers
Submitted to journals indexed - medline
COPE - Answers Committee on Publication Ethics
CSE - Answers Council of Science Editors
FDAAA 2007 - Answers Food and Drug Administration Amendment Act
CONSORT - Answers Consolidated Standard of Reporting Trials - randomized trials with
checklist and flowchart
WAME - Answers World Association of Medical Editors
EQUATOR - Answers Enhancing the Quality and Transparency of Health Rese
PhRMA - Answers Pharmaceutical Research and Manufacturers of America
AMWA - Answers American Medical Writers Association
EMWA - Answers European Medical Writers Association
ICMJE - Answers International Committee of Medical Journal Editors
PRISMA - Answers Preferred Reporting Items for Systematic Reviews and Meta-Analyses
(checklist)
FDA guidance on reprints - Answers Section 401 Food & Drug Administration Modernization Act
FDA guidance on communication of unapproved indications - Answers Unapproved use of
approved drugs "off label"
GPP3 - Answers Good publication practice - understand the document completely and highlight
totally understand document
Joint position on publication of clinical trial results - Answers Which trials, when submitted,
where submitted and what information
All industry clinical trials - positive of negative
Minimum all phase 3 clinical trials to be published
12 months to no later than 18 months
Primary pub - results from all center
Secondary - sub group analysis or results from individual centers
Submitted to journals indexed - medline
